A panelist discusses how their institution evaluates biosimilars for formulary inclusion through a systematic review process ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...

This bipartisan legislation prevents further cuts, provides a modest inflationary adjustment to help ease the cost of care, ...

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

The HYPERION study was evaluating Winrevair in recently diagnosed adults with pulmonary arterial hypertension.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...